AbbVie Inc recalls CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVi
Recalled October 8, 2014 · FDA recall D-1611-2014 · AbbVie
Hazard
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000. · FDA Class II
Units
18,021 Bottles
Sold at
US: Nationwide
Description
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Manufacturer(s)
AbbVie Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →